Insider Transactions in Q4 2025 at Magenta Therapeutics, Inc. (MGTA)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 04
2025
|
Ryan Savitz CFO & CBO |
SELL
Open market or private sale
|
Direct |
20,000
-100.0%
|
$900,000
$45.18 P/Share
|
|
Dec 04
2025
|
Ryan Savitz CFO & CBO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$160,000
$8.44 P/Share
|
|
Nov 14
2025
|
Simrat Randhawa EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
109,031
-96.46%
|
$4,143,178
$38.14 P/Share
|
|
Nov 14
2025
|
Simrat Randhawa EVP, Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
109,031
+33.58%
|
$2,180,620
$20.57 P/Share
|
|
Nov 13
2025
|
Simrat Randhawa EVP, Head of R&D |
SELL
Open market or private sale
|
Direct |
87,507
-58.78%
|
$3,150,252
$36.85 P/Share
|
|
Nov 13
2025
|
Simrat Randhawa EVP, Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
87,507
+26.28%
|
$1,137,591
$13.16 P/Share
|